{"id":3904,"global_id":"herpescureadvocacy.com?id=3904","global_id_lineage":["herpescureadvocacy.com?id=3904"],"author":"205069572","status":"publish","date":"2024-06-22 00:22:50","date_utc":"2024-06-22 04:22:50","modified":"2024-06-22 00:22:50","modified_utc":"2024-06-22 04:22:50","url":"https:\/\/herpescureadvocacy.com\/event\/dr-tj-cradick-excision-biotherapeutics\/","rest_url":"https:\/\/herpescureadvocacy.com\/wp-json\/tribe\/events\/v1\/events\/3904","title":"Dr. TJ Cradick: Excision Biotherapeutics","description":"<p>Join Dr. TJ Cradick, Chief Scientific Officer at Excision Biotherapeutics to learn about Excision Bio pre-clinical work in gene therapy for Herpes Simplex.<\/p>\n<p>Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. A recognized expert in genome editing technologies, Dr. Cradick has developed nucleases, as well as genome editing and gene therapy reagents and methods for CRISPR\/Cas nuclease, TAL Effector Nucleases (TALENs) and Zinc Finger Nucleases (ZFNs), both in his academic work at University of Iowa and the Georgia Institute of Technology, and in-industry at\u00a0Sangamo Therapeutics\u00a0(NASDAQ: SGMO).<\/p>","excerpt":"","slug":"dr-tj-cradick-excision-biotherapeutics","image":false,"all_day":false,"start_date":"2023-02-01 18:00:00","start_date_details":{"year":"2023","month":"02","day":"01","hour":"18","minutes":"00","seconds":"00"},"end_date":"2023-02-01 19:00:00","end_date_details":{"year":"2023","month":"02","day":"01","hour":"19","minutes":"00","seconds":"00"},"utc_start_date":"2023-02-01 23:00:00","utc_start_date_details":{"year":"2023","month":"02","day":"01","hour":"23","minutes":"00","seconds":"00"},"utc_end_date":"2023-02-02 00:00:00","utc_end_date_details":{"year":"2023","month":"02","day":"02","hour":"00","minutes":"00","seconds":"00"},"timezone":"America\/New_York","timezone_abbr":"EST","cost":"","cost_details":{"currency_symbol":"$","currency_code":"USD","currency_position":"prefix","values":[]},"website":"","show_map":true,"show_map_link":true,"hide_from_listings":false,"sticky":false,"featured":false,"categories":[{"name":"Guest Speaker","slug":"guest-speaker","term_group":0,"term_taxonomy_id":47,"taxonomy":"tribe_events_cat","description":"","parent":0,"count":27,"filter":"raw","id":719338665,"urls":{"self":"https:\/\/herpescureadvocacy.com\/wp-json\/tribe\/events\/v1\/categories\/719338665","collection":"https:\/\/herpescureadvocacy.com\/wp-json\/tribe\/events\/v1\/categories"}}],"tags":[],"venue":[],"organizer":[],"custom_fields":[],"json_ld":{"@context":"http:\/\/schema.org","@type":"Event","name":"Dr. TJ Cradick: Excision Biotherapeutics","description":"&lt;p&gt;Join Dr. TJ Cradick, Chief Scientific Officer at Excision Biotherapeutics to learn about Excision Bio pre-clinical work in gene therapy for Herpes Simplex. Excision is developing CRISPR-based therapies to cure&lt;a class=&quot;more-link&quot; href=&quot;https:\/\/herpescureadvocacy.com\/event\/dr-tj-cradick-excision-biotherapeutics\/&quot;&gt;Continue reading &lt;span class=&quot;screen-reader-text&quot;&gt;&quot;Dr. TJ Cradick: Excision Biotherapeutics&quot;&lt;\/span&gt;&lt;\/a&gt;&lt;\/p&gt;\\n","url":"https:\/\/herpescureadvocacy.com\/event\/dr-tj-cradick-excision-biotherapeutics\/","eventAttendanceMode":"https:\/\/schema.org\/OfflineEventAttendanceMode","eventStatus":"https:\/\/schema.org\/EventScheduled","startDate":"2023-02-01T18:00:00-05:00","endDate":"2023-02-01T19:00:00-05:00","performer":"Organization"}}